Here’s What Boosted Wave Life Sciences Ltd. (WVE) in Q4

1 hour ago 2

Soumya Eswaran

Wed, March 25, 2026 astatine 9:08 AM CDT 3 min read

Loomis Sayles, an concern absorption company, released its fourth-quarter 2025 capitalist missive for “Small Cap Growth Fund”. A transcript of the missive is disposable to download here. The tiny caps' net are reaccelerating successful 2025, arsenic the steadfast forecasted a twelvemonth ago. The marketplace besides experienced a low-quality rally wrong the small-cap space. Against this backdrop, the Small Cap Growth Fund underperformed the Russell 2000 Growth Index benchmark successful the quarter, returning 0.51% vs. 1.22% for the benchmark. Heading into 2026, determination are galore reasons to consciousness affirmative astir the economy, net growth, and the banal market. Please reappraisal the Fund’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Loomis Sayles Small Cap Growth Fund highlighted Wave Life Sciences Ltd. (NASDAQ:WVE) arsenic 1 of its starring contributors. Wave Life Sciences Ltd. (NASDAQ:WVE) is simply a clinical-stage biotechnology institution focused connected processing RNA-targeted therapies. On March 24, 2026, Wave Life Sciences Ltd. (NASDAQ:WVE) banal closed astatine $11.63 per share. One-month instrumentality of Wave Life Sciences Ltd. (NASDAQ:WVE) was -20.01%, and its shares gained 24.75% implicit the past 52 weeks. Wave Life Sciences Ltd. (NASDAQ:WVE) has a marketplace capitalization of $2.19 billion.

Loomis Sayles Small Cap Growth Fund stated the pursuing regarding Wave Life Sciences Ltd. (NASDAQ:WVE) successful its 4th fourth 2025 capitalist letter:

"Establishment Labs Holdings, Wave Life Sciences Ltd. (NASDAQ:WVE) and MACOM Technology Solutions Holdings were the apical idiosyncratic contributors overall. Wave Life Sciences is simply a biotech institution focused connected utilizing RNA technologies to dainty assorted conditions. During the quarter, the institution published its archetypal information for a caller obesity people showing a simplification successful abdominous wide portion preserving musculus wide and the banal reacted positively arsenic a result."

$750 Target Stays arsenic Analysts Expect AI Gaps to Close

Wave Life Sciences Ltd. (NASDAQ:WVE) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 45 hedge money portfolios held Wave Life Sciences Ltd. (NASDAQ:WVE) astatine the extremity of the 4th quarter, up from 38 successful the erstwhile quarter. While we admit the imaginable of Wave Life Sciences Ltd. (NASDAQ:WVE) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article